Category: 2024,No. 03

Application of microfluidic chip in basic and clinical ophthalmic research

Authors: Wu Yuqing,  Hong Jiaxu DOI: 10.3760/cma.j.cn115989-20211115-00629 Published 2024-03-10 Cite as Chin J Exp Ophthalmol, 2024, 42(3): 285-289. Abstract                              [Download PDF] [Read Full Text] Microfluidic chip or lab-on-a-chip is a multidisciplinary cross-technology. Among them, organ-on-a-chip technology enables precise regulation of cells and […]

Research progress in the application of in vitro optical quality test system for the assessment of IOL optical quality

Authors: Pan Ruolin,  Liao Xuan,  Lan Changjun DOI: 10.3760/cma.j.cn115989-20221107-00521 Published 2024-03-10 Cite as Chin J Exp Ophthalmol, 2024, 42(3): 290-296. Abstract                               [Download PDF] [Read Full Text] Surgery is currently the only effective treatment for cataract.As the standard of living improves, people’s demand […]

Application of corneal neutrotization in the treatment of neurotrophic keratopathy

Authors: Xu Sanhua,  Wu Jieli,  Shao Yi DOI: 10.3760/cma.j.cn115989-20210825-00476 Published 2024-03-10 Cite as Chin J Exp Ophthalmol, 2024, 42(3): 297-300. Abstract                              [Download PDF] [Read Full Text] Neurotrophic keratopathy (NK) is a degenerative disease in which damage to the corneal nerves leads to […]

Role of adiponectin in fundus neovascularization disease

Authors: Zhang Xiaodan, Yan Hua DOI: 10.3760/cma.j.cn115989-20210110-00020 Published 2024-03-10 Cite as Chin J Exp Ophthalmol, 2024, 42(3): 301-304. Abstract                               [Download PDF] [Read Full Text] Fundus neovascularization disease is a series of clinicopathological changes caused by pathological vascular growth of choroid and […]